EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Peptidomimetic Phenoxymethyl Ketone Warheads as Potent Dual-Mode Inhibitors against SARS-CoV-2 M pro and Cathepsin

Miriam R B Porzberg iD, G J Mirjam Groenewold iD, Heyrhyoung Lyoo iD, Alexander K M H Jakob, Willem H C Titulaer, Lorenzo Cavina, Katrien C K Poelaert, Marleen Zwaagstra, Cindy E J Dieteren, Jaap G H Lemmers, S Hakim Hamdani iD, Bernd N M van Buuren und 9 weitere

Journal of Medicinal Chemistry · 2025

DOI: 10.1021/acs.jmedchem.4c03147 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Miriam R B Porzberg und 20 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Molecules and Materials, Radboud University, Heyendaalseweg 135, Nijmegen 6525 AJ, The Netherlands. Hauptthemen laut MEDLINE: SARS-CoV-2, Peptidomimetics, Cathepsin L, Antiviral Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ZonMw, Health~Holland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Five years after the onset of the COVID-19 pandemic, there still is an unmet need for novel antivirals to battle SARS-CoV-2 and other coronaviruses. For this purpose, the development of peptidomimetics against the SARS-CoV-2 main protease (Mpro) and host proteases human cathepsin L (hCTSL) and cathepsin B (hCTSB) is an attractive strategy. These dual-mode antivirals target both viral entry and replication, which could be a suitable alternative to highly specific Mpro and CTS inhibitors. Herein, we examined the inhibitory activity, physicochemical and ADME properties, metabolic stability, and in vivo PK parameters of peptidomimetic inhibitors bearing a potent phenoxymethyl ketone warhead. Our compounds showed nanomolar inhibition of both Mpro and hCTSL/hCTSB and efficiently inhibited SARS-CoV-2 replication in cell culture. Furthermore, we studied metabolism and the impact of coadministration with the CYP-inhibitor ritonavir. Taken together, we report 1 as broad-spectrum coronavirus inhibitor with attractive properties to be pursued in in vivo efficacy studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2PeptidomimeticsCathepsin LAntiviral AgentsCathepsin BCoronavirus 3C ProteasesKetonesCOVID-19 Drug TreatmentProtease InhibitorsHumansAnimalsVirus ReplicationCOVID-19Vero Cells

Substanzen

PeptidomimeticsCathepsin LAntiviral AgentsCathepsin BCoronavirus 3C ProteasesCTSL protein, humanKetonesProtease InhibitorsCTSB protein, human

Autor:innen und Institutionen

  • Institute for Molecules and Materials, Radboud University, Heyendaalseweg 135, Nijmegen 6525 AJ, The Netherlands.
  • Molecular Virology Laboratory, Leiden University Center for Infectious Diseases, Leiden University Medical Center, Albinusdreef 2, Leiden 2333ZA, The Netherlands.
  • Virology Section, Division of Infectious Diseases & Immunology, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 1, Utrecht 3584 CL, The Netherlands.
  • Protinhi Therapeutics, Transistorweg 5, Nijmegen 6534 AT, The Netherlands.
  • Avivia BV, Transistorweg 5, Nijmegen 6534 AT, The Netherlands.
  • Artemis Bioservices, Molengraaffsingel 10, Delft 2629 JD, The Netherlands.

ORCID-Profile: Miriam R B Porzberg, G J Mirjam Groenewold, Heyrhyoung Lyoo, S Hakim Hamdani, Martin C Feiters, Frank J M van Kuppeveld, Martijn J van Hemert, Floris P J T Rutjes

Förderung

  • ZonMw
  • Health~Holland

Zitieren

APA

Porzberg, M. R. B., Groenewold, G. J. M., Lyoo, H., Jakob, A. K. M. H., Titulaer, W. H. C., Cavina, L., Poelaert, K. C. K., Zwaagstra, M., Dieteren, C. E. J., Lemmers, J. G. H., Hamdani, S. H., van Buuren, B. N. M., Ackerschott, B., Platteeuw, J., Michorius, J., Martina, B. E. E., Feiters, M. C., Gironés, D., van Kuppeveld, F. J. M., …, & Rutjes, F. P. J. T. (2025). Peptidomimetic Phenoxymethyl Ketone Warheads as Potent Dual-Mode Inhibitors against SARS-CoV-2 M pro and Cathepsin. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c03147

Vancouver

Porzberg MRB, Groenewold GJM, Lyoo H, Jakob AKMH, Titulaer WHC, Cavina L, et al. Peptidomimetic Phenoxymethyl Ketone Warheads as Potent Dual-Mode Inhibitors against SARS-CoV-2 M pro and Cathepsin. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.4c03147

BibTeX
@article{Porzberg2025,
  author = {Porzberg, Miriam R B and Groenewold, G J Mirjam and Lyoo, Heyrhyoung and Jakob, Alexander K M H and Titulaer, Willem H C and Cavina, Lorenzo and Poelaert, Katrien C K and Zwaagstra, Marleen and Dieteren, Cindy E J and Lemmers, Jaap G H and Hamdani, S Hakim and van Buuren, Bernd N M and Ackerschott, Bart and Platteeuw, Johannes and Michorius, Joey and Martina, Byron E E and Feiters, Martin C and Gironés, Daniel and van Kuppeveld, Frank J M and van Hemert, Martijn J and Rutjes, Floris P J T},
  title = {Peptidomimetic Phenoxymethyl Ketone Warheads as Potent Dual-Mode Inhibitors against SARS-CoV-2 M pro and Cathepsin},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  doi = {10.1021/acs.jmedchem.4c03147}
}
Kostenlos starten →